Tech Company Financing Transactions
Cartherics Funding Round
Cartherics, operating out of Notting Hill VIC, secured $15 million from private investors.
Transaction Overview
Company Name
Announced On
10/1/2024
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the clinical trial for CTH-401, its lead cell therapy for ovarian cancer, and expand its pipeline to include other diseases.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
12 Ferntree Place
Notting Hill VIC, 3168
Australia
Notting Hill VIC, 3168
Australia
Phone
Website
Email Address
Overview
Developing more precise and more accessible treatment alternatives for patients with solid cancers; Cartherics works to create precisely-defined immunotherapy treatments to combat a variety of cancers. We take a multi-platform approach combining the best components of immune defences utilising gene editing and CAR technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Bob Moses
Chief Executive Officer
Alan Trounson
Chief Operating Officer
Ian Nisbet
Chief Scientific Officer
Walid Azar
VP - Marketing
Christine Filippis
Browse more venture capital transactions:
Prev: 10/1/2024: SUMA Wealth venture capital transaction
Next: 10/1/2024: Artisan venture capital transaction
Share this article
About Our VC Transactions Data
We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs